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Fluorescence microscopyThe interaction of antipsychotic drugs (AP) with lipids and the subsequent lipid reorganization on model
membranes was assessed using a combination of several complementary biophysical approaches
(calorimetry, plasmon resonance, ﬂuorescence microscopy, X-ray diffraction and molecular modeling). The
effect of haloperidol (HAL), risperidone (RIS), and 9-OH-risperidone (9-OH-RIS) was examined on single lipid
and mixtures comprising lipids of biological origin. All APs interact with lipids and induced membrane
reorganization. APs showed higher afﬁnity for sphingomyelin than for phosphatidylcholine. Cholesterol
increased AP afﬁnity for the lipid bilayer and led to the following AP ranking regarding afﬁnity and structural
changes: RIS N9-OH-RIS NHAL. Liquid-ordered domain formation and bilayer thickness were differentially
altered by AP addition. Docking calculations helped understanding the observed differences between the APs
and offer a representation of their conformation in the lipid bilayer. Present results indicate that AP drugs may
change membrane compartmentalization which could differentially modulate the signaling cascade of the
dopamine D2 receptor for which APs are ligands.ie Curie-Paris 6, UMRS 7203,
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Antipsychotic drugs (AP) exert their therapeutic effects by acting
preferentially in the brain [1–3]. Although AP compounds have
chemically diverse structures and receptor afﬁnity proﬁles, all
interfere with dopaminergic transmission through their antagonistic
activity on D2 receptors (D2R). This mechanism is generally
acknowledged to account for their therapeutic activity. The thera-
peutic effects of the “ﬁrst generation” antipsychotics are in direct
proportion to their level of dopamine D2 receptor blockade. Second
generation antipsychotics so-called atypical such as risperidone and
olanzapine, were introduced in the 1990s. Their antipsychotic efﬁcacy
is associated with a combination of receptor blockade (in particular a
high 5HT2/D2 afﬁnity ratio, and/or a high D2 receptor dissociation
rate). They were proposed because of a better overall tolerance [3,4].
In addition to their receptor activity and because of their
amphiphilic properties, APs also accumulate in brain tissue and inparticular in cell membranes [5,6]. They can thus also exert several
non-receptors targeted activities at the membrane lipid level. Several
lines of evidence have indicated that APs interfere with themembrane
lipid organization and metabolism.
Such interference may take place either by intercalation into the
membrane and/or via a modiﬁcation of cholesterol biosynthesis or
bioavailability. Altogether, thesemodiﬁcationsmay have an impact on
the signaling process due to the induced changes of the receptor lipid
environment or via changes in cholesterol bioavailability. Cholesterol
is a key component of lipid rafts, membrane domains enriched in
sphingolipids [7,8]. Lipid rafts serve as major platforms for the
initiation, propagation, andmaintenance of signal transduction events
[7]. AP ability to change liquid-ordered phase characteristics was
already described for some APs in previous works [9,10]. Thus, it is not
surprising that dysfunctions in cholesterol synthesis, storage, trans-
port, and removal may lead to important cell physiology disturbances
[11]. As early as 1965, Summerly and Yardley were able to
demonstrate that haloperidol inhibits cholesterol biosynthesis in rat
skin [12]. A recent publication studying neuroblastoma cultured cells
was able to demonstrate a speciﬁc effect of haloperidol on nervous cell
membrane, inducing disruption of lipid rafts, redistribution of
ﬂotillin-1, and impairment of insulin signaling [13]. In this study,
haloperidol was shown to inhibit cholesterol and several pre-
cholesterol sterols biosynthesis, inducing a decrease in cholesterol
content in lipid rafts. Interestingly, supplementation with free
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sition and functionality. It was not clear whether the cholesterol
addition was interfering with the cholesterol biosynthesis regulation
itself or via competition with haloperidol.
Another line of evidence is related to the effect of APs in the
treatment of cancer cell proliferation. Among several potential
mechanisms, it has been suggested that interaction of APs with
some cholesterol-related mechanisms could play a major role in the
antipsychotic synergistic effect against cancer cell proliferation. This
effect may work through regulation by AP compounds of key genes
implicated in cholesterol biosynthesis [14]. For instance HMGCR (3-
hydroxy-3-methylglutaryl-CoA reductase) and LDLR (low density
lipoprotein receptor) were shown to be regulated by pimozide and
olanzapine, ﬁrst and second generation APs, respectively [15].
Another hypothesis is that APs bind to membrane lipids and inhibit
membrane trafﬁcking between the late Golgi and endosomal compart-
ments, thus hampering intracellular cholesterol transport [16].
In the present paper, we show that AP drugs interfere with
membrane organization depending on their chemical structure and
independently to their so-called atypicality. AP interference with
membrane could modify the relative spatial positioning of the
membrane phospholipids, in particular those surrounding the receptors
(GPCR, G-protein-coupled receptors). This could be described as an
indirect effect of AP on receptors activity. Furthermore, the creation of
particular lipid environments caused by APs can lead to a modiﬁed
compartmentalization of the signaling cascades by the speciﬁc
recruitment on these platforms of certain protein and downstream
effectors, leading overall to different signaling pathways [17]. This effect
on signalization caused by APs is hypothesized to be independent from
their intrinsic D2 binding afﬁnity. This could explain why two AP
molecules with a same in vitro receptor binding proﬁle for D2 receptors
may be associated with a different signaling pattern.
In order to show differences not only between ﬁrst and second
generation APs but also between atypical themselves, we studied the
effect of a ﬁrst (haloperidol), and second generation atypical AP
compounds (risperidone and 9-OH-risperidone) on well characterized
membrane models. These atypical compounds were selected as they
possess both a similar D2/5HT2 binding afﬁnity [18] and a small but
signiﬁcant difference in terms of chemical structure. Herein, the
afﬁnities and effects induced by these molecules on the lateral
organization ofmodelmembranes were investigated using calorimetry,
plasmon resonance, ﬂuorescence microscopy, X-ray diffraction and
docking calculations. The studies shed light on the different behavior of
such molecules on lipids, especially regarding cholesterol, which we
attempted to correlate with their distinct biological response.
2. Materials and methods
2.1. Materials
Dipalmitoylphosphatidylcholine (DPPC) was purchased from
Genzyme (Switzerland) and was used without further puriﬁcation;
brain sphingomyelin (brain SM), egg phosphatidylcholine (egg PC)
were purchased from Sigma-Aldrich. The ﬂuorescent lipid analogue L-
α-phosphatidylethanolamine-N-(lissamine rhodamine B sulfonyl)
(egg-transphosphatidylated, chicken) (egg Rhod PE) and cholesterol
were obtained from Avanti Polar Lipids (Alabaster, AL). The
antipsychotic compounds, risperidone (RIS) and 9-OH-risperidone
(9-OH-RIS) were kindly provided by Johnson & Johnson Pharmaceu-
ticals and haloperidol (HAL) was purchased from Sigma-Aldrich.
2.2. Preparation of lipid vesicles
2.2.1. Preparation of multilamellar vesicles (MLV) for DSC
Lipid ﬁlms were made by dissolving the appropriate amounts of
lipid in a mixture of chloroform and methanol 2/1 (v/v), followed bysolvent evaporation under nitrogen to deposit the lipid as a ﬁlm on
thewall of a test tube. The AP drugs whichwere dissolved inmethanol
and chloroform were added to the lipid mixture prior to evaporation
at antipsychotic-to-lipid molar ratio (AP/L) of 1/100, 1/50, 1/25 and 1/
10. The total lipid concentration used varied from 1 mg/ml for DPPC to
6 mg/ml in the case of DPPC/cholesterol (95/5 mol/mol) mixture.
Final traces of solventwere removed in a vacuum chamber attached to
a liquid nitrogen trap for 3–4 h. Films were hydrated with 10 mM Tris,
0.1 M NaCl, 2 mM EDTA, pH 7.6 (Tris buffer) and extensively mixed
above the lipid phase transition temperature to obtain MLVs.
2.2.2. Preparation of giant unilamellar vesicles (GUV)
The electroformation method developed by Angelova and Dimi-
trov [19] was used to form the vesicles. Binary and ternarymixtures of
egg PC, brain SM, and cholesterol were prepared (egg PC/brain SM 50/
50 mol/mol, egg PC/brain SM 45/45/10 mol/mol/mol) with and
without antipsychotic drugs (AP/L ratio: 1/10). Brieﬂy, the speciﬁc
electroformation protocol was the following: each lipid mixture was
prepared in diethyl ether/chloroform/methanol 70/20/10 v/v, at
0.5 mg/ml total lipid. APs were dissolved in a chloroform/methanol
(9/1 v/v) solution and added to the lipid mixture (AP/L ratio: 1/10)
before solvent evaporation. Three droplets of AP/L solution (1.5 μl)
were deposited (avoiding sliding) on each of the two parallel
platinum wires (diameter 0.8 mm, distance between axes 3 mm) of
the working chamber and dried under vacuum for 1 h. An alternating
current (ac) electrical ﬁeld, 10 Hz, 100 mVpp, was applied to the
electrodes. A thermocouple (0.2 °C accuracy, Type T, TC S.A., Dardilly,
France), positioned at a distance of about 0.5 mm from the one of the
electrode, was used to monitor the temperature. Warm (45 °C) buffer
solution (2 ml of 1 mM HEPES, pH 7.4, conductivity σ=59 μS/cm)
was added into the working chamber (avoiding agitation). The
applied voltage was gradually increased up to 400 mVpp during
15 min as the temperature in theworking chamber wasmaintained at
45 °C. A coverslip was used to avoid buffer evaporation. After 2 h, at
least 20 GUVs with diameters of 60–90 μm were present on each
electrode.
2.2.3. Preparation of multilamellar vesicles for XRD
Liposomes for X-ray diffraction studies were prepared by dissol-
ving lipids in chloroform/methanol (2/1, vol/vol) in a 33/33/34 egg
PC/brain SM/cholesterol molar ratio. All antipsychotic compounds
were incorporated at an AP/L ratio of 1/200. The organic solvent was
subsequently evaporated under a stream of oxygen-free dry nitrogen
at 45 °C and any remaining traces of solvent were removed by a 2-day
storage under high vacuum at 20 °C. AP drugs were added before
solvent evaporation. Dry lipids were hydratedwith an equal weight of
a 10 mM Tris–HCl, NaCl 150 mM, CaCl2 0.1 mM (pH 7.5) buffer. The
aqueous dispersion of lipids was thoroughly stirred with a thin
needle, sealed under argon, and gently shaken at 50 °C during 2 h. The
samples were stored under argon at 4 °C. X-ray examination was
conducted after 2 h at 65 °C and a 2-h equilibration at 20 °C and after
stirring. X-ray diffraction recording was performed after 5-min
equilibration at 37 °C.
2.3. Methods
The choice of lipids and their ratios in the different experiments
were made for the ultimate purpose of the appraisal of the effect of AP
on the organization of the lipid membrane which was mimicked by
the PC/SM/cholesterol ternary mixtures. Due to the inherent
sensitivity and limitations of each biophysical method used, differ-
ences in terms of lipid nature and lipid ratios used in mixtures as well
as AP concentrations were inevitable. Justiﬁcation of the choice of
lipid(s) will be given for each method. The smallest AP concentration
able to exhibit differential changes in the given mixture was chosen
for each study.
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The calorimetry was performed on a high-sensitivity Differential
Scanning Calorimeter (Calorimetry Sciences Corporation). A scan rate
of 1 °C/minwas usedwith a 15-min delay between sequential scans in
a series that allow for thermal equilibration. Data analysis was
performed with the ﬁtting program Cpcalc provided by CSC and
plotted with Igor (Wavemetrics). Four heating and cooling scans were
performed for each analysis to ensure thermogram reproducibility.
MLVs were used in this study because heating of LUVs induces their
fusion into larger aggregates [20], this process increasing the
complexity of the resulting thermograms. This problem becomes
evenmore complicated whenmore than a lipid is used in the mixture.
Different AP/L ratios were used to monitor the effect of AP drug
concentration on lipid perturbation.
2.3.2. Plasmon waveguide resonance (PWR) spectroscopy
PWR spectra are produced by resonance excitation of conduction
electron oscillations (plasmons) by light from a polarized CW laser
(He–Ne; wavelength of 632.8 and 543.5 nm) incident on the back
surface of a thinmetal ﬁlm (Ag) deposited on a glass prism and coated
with a layer of SiO2 (see Salamon et al. [21] for additional
information). Experiments were performed on a beta PWR instru-
ment from Proterion Corp. (Piscataway, NJ) that had an angular
resolution of 1 mdeg. The sample to be analyzed (a lipid bilayer
membrane) was immobilized on the resonator surface and placed in
contact with an aqueousmedium, intowhich drugs can be introduced.
The self-assembled lipid bilayers were formed using a solution (in
butanol/squalene 0.93/0.07 v/v) of 8 mg/ml of lipid (either egg PC,
brain SM, a 75/25 mol/mol mixture of egg PC and brain SM, egg PC/
cholesterol 95/5 mol/mol or brain SM/cholesterol (95/5). The method
used to make the lipid bilayers is based on the procedure by Mueller
and Rudin to make black lipid membranes across a small hole in a
Teﬂon block [22]. To accomplish this, a small amount of lipid solution
was injected into the oriﬁce in a teﬂon block separating the silica
surface of the PWR resonator from the aqueous phase. Spontaneous
bilayer formation was initiated when the sample compartment was
ﬁlled with aqueous buffer solution (see Salamon et al. [21]). The
molecules (such as lipids and drugs) deposited onto the surface
plasmon resonator change the resonance characteristics of the
plasmon formation and can thereby be detected and characterized.
PWR spectra, corresponding to plots of reﬂected light intensity versus
incident angle, can be excitedwith light whose electric vector is either
parallel (s-polarization) or perpendicular (p-polarization) to the
plane of the resonator surface. Spectral simulation [21] and/or
graphical analysis [23] allow one to obtain information about changes
in the mass density, structural asymmetry, and molecular orientation
induced by bimolecular interactions occurring at the resonator
surface. Here, the graphical analysis method was employed. Brieﬂy
this method consists in deconvoluting the components of the PWR
spectra that are due to changes in mass in the lipid ﬁlm from those
that are due to changes in structural anisotropy. Such distinction can
be done based on the magnitude and direction of the PWR spectra
shifts observed for the p- and s-polarized light [23,24].
The drug was injected into the cell sample compartment contain-
ing the cell membrane in an incremental fashion. The amount of lipid
bound drug is associated with the resonance shift observed by PWR,
the total amount being the amount of drug added to the chamber.
Since the PWR is only sensitive to the optical properties of material
that is deposited on the resonator surface, there is no interference
from thematerial that is in the bulk solution. Moreover, the amount of
boundmaterial is much smaller than the total amount of drug present
in the bulk solution, and it is assumed that the bulk material is able to
freely diffuse and equilibrate with the membrane. Data ﬁtting
(GraphPad Prism) through a hyperbolic saturation curve provides
the dissociation constants. It should be noted that since concomitantly
with the binding process other processes, such as membranereorganization and solvation, occur the dissociation constants
correspond to apparent dissociation constants.
2.3.3. Fluorescence microscopy
Fluorescence microscopy was performed under a controlled
temperature with a Peltier microscope stage at rate of 0.2 °C/min.
The accessible temperature range for the sample was between 3 °C
and 45 °C. Egg Rhod PE headgroup-labeled lipid analogue (0.8 mol%)
was used in our study as a ﬂuorescent marker to probe the effect of AP
on themicro-scale miscibility transition temperature. As the egg Rhod
PE partitions predominantly in the disordered phase, it was excluded
from the more ordered phase. Its higher afﬁnity for disordered phase
results from the existence of unsaturated fatty acids which prevents
from tight packing of the N-acyl chains. Such afﬁnity, however, is not a
common feature of the headgroup-labeled rhodamine PE. For
example, the afﬁnity of Rhodamine-DPPE for different phases could
change depending on the probed mixtures [25,26]. The assignment of
phases is not problematic using ﬂuorescence in the case of coexisting
gel/liquid-disordered phases because gel domains exhibit leaf-like
shapes and do not merge while this is not the case when liquid/liquid
immiscibility is observed. The ﬂuorescent probe assignment of phases
could be confusing because the two phases share similar physico-
chemical properties. In this case, phase assignment results from
indirect observation provided by systematic changes of SM and
cholesterol concentration. For instance, at low SM and cholesterol
concentrations the fraction of liquid-ordered domains must be
smaller than liquid-disordered ones. To minimize photo-induced
oxidation during the ﬂuorescence observation, the following preven-
tive measures were undertaken: low power illumination (50 W Hg
arc lamp light), maximum closed aperture, and low dye concentration
(up to 0.8 mol% for epiﬂuorescence measurements) [27,28]. Phase
separation was conﬁrmed only when visualized immediately after
opening the illumination with exposure time from 300 to 800 ms.
The vesicles were observed using a Zeiss Axiovert 135 microscope,
equipped with a 63× long working distance objective lens (LD
Achroplan Ph2). The observations were recorded using a Zeiss
AxioCam HSm CCD camera connected to an image recording and
processing system (Axiovision, Carl Zeiss, Wien, Austria). The phase
morphology transformations of the heterogeneous GUV membrane
were followed in ﬂuorescence by the Zeiss ﬁlter set Ex/Em=546/
590 nm. As a function of time, fusion and alteration of the domain
shape and size can be spotted by video microscopy.
The term “micron-scale miscibility transition temperature” was
ﬁrstly described by Veatch and Keller [29]. This phenomenon
corresponds to the temperature at which domain formation at
micron-scale can be observed. Its assessment can be done by the
observation of the appearance and disappearance of domains during a
temperature cooling and subsequent heating. Transition temperature
is deﬁned as the average of these two points. Standard deviations
correspond to the averaged data from 30 vesicles. Three experiments
were systematically carried out for each mixture as 10 vesicles were
probed per experiment.
2.3.4. Small and wide angle X-ray diffraction using synchrotron radiation
Measurements were performed at station I22 of the Diamond
Synchrotron Radiation (UK) (www.diamond.ac.uk). Simultaneous
small-angle (SAXS) and wide-angle (WAXS) X-ray scattering inten-
sities were recorded (Application SM4691). The duration of the scan
was 15 s during which continuous value integration was processed.
The camera length (SAXS) was 1.2 m of the sample. Detector
calibration was realized using silver behenate. The lipid dispersion
sample (20 μl) was sandwiched between two thin mica windows
(0.5 mm apart). The samples were recorded at 37 °C after a 5-min
period for temperature equilibration. Data reduction and analysis
were performed using Peak Fit 4.12 (Systat Software Inc.).
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standard procedures [30]. The scattering intensity data from the ﬁrst four
orders of the Bragg reﬂections from the multilamellar liposomes were
used to generate electron density proﬁles [31] for the Lo and Ld repeat
structures detected in the ternary lipid dispersions. After correction of the
rawdata for detector channel response and subtraction of the background
scattering frombothwater and the sample cellwindows, each Bragg peak
was ﬁtted by a Lorentzian+Gaussian distribution. The square root of
integratedpeak intensity I(h) is derived todetermine the form factor F(h):
F(h)=h√I(h), h=order of peak reﬂection, I(h)=integrated intensity of
each respective reﬂection.
Electron density proﬁles were calculated by the Fourier synthesis:
ρ(z)=∑±F(h)cos(2πh z/d), d=dspacing=dpp+dW (dpp: phos-
phate–phosphate bilayer thickness, dW: hydration layer).These curves
are sigmoidal functions where the maxima are indicative of the
electron-enriched membrane region and stand for the phosphorus
polar head-group, while the minima represent the electron-deprived
area, standing for the fatty acid tail at the center of the bilayer.
2.3.5. Docking calculations
Haloperidol, 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-
ﬂuorophenyl)-butan-1-one (DB00502), risperidone, 4-[2-[4-(6-ﬂuoro-
benzo[d]isoxazol-3-yl)-1-piperidyl]ethyl]-3-methyl-2,6-diazabicyclo
[4.4.0]deca-1,3-dien-5-one (DB00734), and 9-OH-risperidone, 3-(2-(4-
(6-ﬂuoro-3-(1,2-benzisoxazolyl))-1-piperidinyl)ethyl)-6,7,8,9-tetra-
hydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one
(DB01267) 3D coordinates were obtained from www.drugbank.ca and
treated as ﬂexible ligands. The previously equilibrated bilayer contain-
ing 128 POPC lipid molecules and 974 water molecules was obtained
from http://persweb.wabash.edu/facstaff/fellers/. A grid box containing
60×60×126 points in x, y, z axis, respectively, with a point spacing set
to 0.354 Å (approximately 20,100 Å3) was constructed from the
membrane center. The search for the best docking scores using
AutoDock 4.2 (AutoDock 4 Scoring Function [32,33]) and AutoDock
Vina [34] was performed for each individual ligand. Samples contained
all hydrogen atoms and partial charges were assigned using Gasteiger
method calculated by the AutoDock Tools. The standard docking
procedure for a rigid membrane and ﬂexible ligands was used for 3
independent runs per ligand with 10 ﬁnal structures selected based on
the energy score. AutoDock runs were performed using a Cygwin
(www.Cygwin.org) and the Bash shell script in a dual processor AMD64
Windows XPmachine. Only the 3 lowest afﬁnity energy structures from
each ﬁnal score were selected for analysis.
3. Results
3.1. Calorimetric (DSC) measurements
The phase transition temperature and thermodynamics of lipid
phase transitions are extremely sensitive to the presence of
exogenously added compounds. Indeed DSC has been used in a
variety of peptide–lipid studies [35–40] as well as to investigate the
effect of amphiphilic drugs on lipids [10,41–43]. Most lipids exhibit
two endothermic events, a less energetic pre-transition (P′β) at lower
temperature that arises from the conversion of the L′β to the P′β and a
higher energy main transition from the conversion of P′β to Lα
occurring at higher temperature. Therefore, monitoring changes in
these parameters can provide valuable information regarding the
ability of molecules to interact and/or disrupt the lipid acyl chain
packing, providing insight into their interaction mechanism. The
following lipid mixtures were employed in these studies: DPPC and
DPPC/cholesterol (95/5 mol/mol).
3.1.1. DPPC
DPPC presents a pre-transition around 34.5 °C and a main phase
transition at 41.6 °C (Fig. 1 and Table 1). RIS and 9-OH-RIS did notaffect the phase transition of DPPC whereas HAL greatly affected both
the pre-transition (that was abolished at AP/L≥1/50) and the main
phase transition with a reduction in the phase transition temperature
(Tm) and a large effect on the cooperativity of the transition
(measured by the half-width of the thermogram) (Fig. 1 and Table 1).
3.1.2. DPPC/cholesterol (95/5 mol/mol)
The addition of cholesterol to a lipid decreases the cooperativity of
the transition due to its intercalation between the lipid fatty acid
chains leading to a broadening of the phase transition starting from
very low concentrations of cholesterol [for an example, see [44]]. The
addition of RIS to DPPC/cholesterol (95/5, mol/mol) leads to an
increase in the Tm (0.6 °C) and slight increase in ΔH accompanied by
an increase in the cooperativity of the transition. Similar results were
observed for 9-OH-RIS, although smaller with an increase in Tm of
only 0.3 °C and a smaller increase inΔH. HAL had the opposite effect, it
led to a 0.8 °C decrease in Tm and to a considerable decrease in the
cooperativity of the transition accompanied by an increase in the ΔH
(Fig. 1 and Table 2).
It should be noted that DSC experiments have also been performed
with SM and the APs exerted no signiﬁcant effect in this lipid
thermogram.
3.2. Plasmon waveguide resonance (PWR) spectroscopy measurements
Herein, PWR was used to measure the afﬁnity of AP drugs for lipid
bilayers composed of egg PC, egg PC/brain SM (75/25 mol/mol), egg
PC/cholesterol (95/5 mol/mol), brain SM and brain SM/cholesterol
(95/5 mol/mol) and the drug-induced changes in the lipid mass
density and organization. Apparent dissociation constants in the tens
of μM (17 to 50 μM) were obtained for the interaction of the AP drugs
with egg PC and in the low μM range for the interaction with egg PC/
brain SM and brain SM. The greater effects on AP drug afﬁnity for the
lipid were observed in presence of cholesterol (either when mixed
with egg PC or brain SM), especially in the case of RIS and 9-OH-RIS
where low nanomolar afﬁnities were observed (Table 3).
In order to characterize the mass and the structural changes that
accompany the interaction of the AP drugs with the lipid bilayer, one
has to either obtain the optical parameters from the PWR spectra by
ﬁtting procedures (see Salamon et al. [21] for details) or to use a more
simple method based on graphical analysis, that allows one to
distinguish between mass and anisotropy changes (fully described in
Salamon and Tollin [23]). Herein, we have chosen to perform a
graphical analysis, which, by plotting the data, points on a (s, p)
coordinate system containing both mass and structural axis, placed
according to the sensitivity factor of the PWR sensor (see Materials
and methods for details). In Table 3 one can see the direction and
magnitude of p- and s-polarization spectral changes induced by the AP
drugs. Overall one can see that all AP drugs lead to different spectral
changes, most of them corresponding to positive shifts in p- and s-
polarization (except for the interaction of RIS with egg PC/brain SM,
egg PC/cholesterol, brain SM and brain SM/cholesterol where negative
shifts for p-pol were observed). The evaluation of those spectral shifts
for mass and structural changes, by the method above described, has
been performed. Positive spectral shifts for both p- and s-pol light
with p-pol shiftsNs-pol shifts lead to large changes in mass (70% to
80% depending on the magnitude of p- and s-pol shifts) and small
changes in structure. The component in the mass change decreased
when p-pol shifts become smaller than s-pol shifts (both of them
being positive) which is the case for the interaction of 9-OH-RIS with
egg PC. In the case where negative shifts are observed for p-pol and
positive shifts are observed for s-pol (as it is the case for the
interaction of 9-OH-RIS with egg PC/SM, egg PC/cholesterol, brain SM
and brain SM/cholesterol) structural changes predominate over mass
changes (Table 3).
Fig. 1. High sensitivity DSC heating scans. Panel a: effect on DPPC (solid line) of the addition of haloperidol (——), risperidone (- - -) and 9-OH-risperidone (⋅⋅⋅) at a ratio 1/10 on the
thermotropic phase behavior. Panel b: effect of the same antipsychotics (ratio 1/10) on DPPC/cholesterol (95/5 mol/mol) multilamellar vesicles. Thermodynamic parameters are
given in Tables 1 and 2.
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3.3.1. Egg PC/brain SM mixture
A gel/liquid-disordered (Lβ/Ld) phase separation is observed in the
egg PC/brain SM (50/50 mol/mol) mixture after HAL, 9-OH-RIS and
RIS addition (AP/L ratio: 1/10) (Supplementary data Fig. 1). The
control mixture exhibited Lβ/Ld micron-scale miscibility transition at
28.4 °C (Table 4). All APs induced a decrease in the temperature of gel
domain formation (Table 4). RIS addition is associated with a stronger
decrease in Tm (15.2 °C) followed by 9-OH-RIS and HAL (at about
24 °C) compared to the control condition.
3.3.2. Egg PC/brain SM/cholesterol mixture
Two types of information can be derived from our results: the ﬁrst
one corresponds to the micron-scale miscibility transition tempera-
ture; the second is related to the shape and fusion ability of the
micron-scale domains.
In the control condition (egg PC/brain SM/cholesterol, 45/45/
10 mol/mol/mol), a micron-scale miscibility transition temperature
(liquid-ordered/liquid-disordered (Lo/Ld) phase separation) was
detected at 23.3 °C (Table 4). For clarity purposes, data are shown at
21 °C (Fig. 2a). Addition of APs to the control mixture led to Lo/Ld
phase separation at lower temperatures (Table 4). RIS exhibited the
strongest effect (19.7 °C).
In the control ternary mixture, a perfectly round shape and fusion
ability of the Lo domains (Fig. 2a–c), indicative of a liquid/liquid
immiscibility was detected up to 15 °C (Fig. 2b and c, marked by the
arrows). Addition of HAL, 9-OH-RIS and RIS (at 1/10 AP/L ratio) led to
a fusion of Lo domains which is still observable at 12 °C, 8 °C and 4 °C
for mixtures comprising HAL (Fig. 2e–g), 9-OH-RIS (Fig. 2i–k) and RIS
(Fig. 2m–p), respectively (marked by the arrows). Fusion ability ofTable 1
Thermodynamic parameters obtained byDSC after addition of haloperidol, risperidone and 9-OH-
AP drug AP/Lipid Ratio T pre-trans. (°C) ΔH pre-trans. (KJ/mol) ΔS pre-
HAL DPPC alone 34.5±0.2 4.6±0.3 16±1
1/100 25±0.4 0.8±0.2 4±0.3
1/50 – – –
1/25 – – –
1/10 – – –
9-OH-RIS DPPC alone 34.5±0.2 4.6±0.3 17±1
1/100 34.5±0.2 4.6±0.3 17±1
1/50 34.5±0.2 4.6±0.4 17±2
1/25 34.5±0.2 4.6±0.4 17±2
1/10 34.5±0.2 4.6±0.3 17±1
RIS DPPC alone 34.5±0.2 4.6±0.3 17±1
1/100 34.5±0.2 4.6±0.4 17±2
1/50 34.7±0.2 4.6±0.3 17±1
1/25 34.6±0.3 4.6±0.4 17±2
1/10 35.2±0.3 4.6±0.4 17±2
– Pretransition disappearance.
Note: experiments were performed 3 times.these domains is indicative of a more liquid condition of Lo domains
compared to the control, this property beingmore pronounced for RIS.
In the control mixture, at temperatures below 15 °C, the fusion of the
domains led to non-circular forms, demonstrating the presence of a
gel phase in conjunction with Lo/Ld (Fig. 2d). Such non-circular
domains were also observed for 9-OH-RIS and HAL mixtures at 4 °C
(Fig. 2h and l) similarly to the control (Fig. 2d).
3.4. X-ray diffraction data. Electron density proﬁle
Electron density proﬁles (EDP) for each of the two Lo/Ld identiﬁed
phases of the egg PC/brain SM/cholesterol (33/33/34 mol/mol/mol)
ternary mixture are shown in Fig. 3. Addition of AP (AP/L ratio: 1/200)
was associated with signiﬁcant proﬁle changes for both phases. For
the Ld phase, a shoulder is evidenced after AP addition between the
dense phosphorus and oxygen-rich headgroup position and the
minima in the bilayer center. This effect is more pronounced in this
phase for 9-OH-RIS and HAL and is not visible for RIS. In contrast,
while such shoulder exists for the control condition for the Lo phase,
AP addition is associated with a smoothing effect but not for HAL.
3.5. Docking calculations
HAL inserts in the POPC lipid bilayer in a bent conformation,
mostly due to strong hydrophobic interactions between the two
benzene rings (4-p-chlorophenyl and 4-p-ﬂuorphenyl) which are
pointing towards the bilayer center (Fig. 4e and f). When viewed from
the top of the bilayer, its bent structure is prone to occupy a large
molecular surface leading to a great perturbation in both the lipid–
lipid headgroup and fatty acid chain packing. The molecule is able to
enter about 2/3 into the lipid monolayer (Fig. 4e). Hydrogen bondsrisperidone to DPPC. AP/L ratio (mol/mol): 1/100, 1/50, 1/25 and 1/10were studied for all AP.
trans. (J/mol) Tm (°C) ΔH main trans. (KJ/mol) ΔS main trans. (J/mol)
41.5±0.2 43.5±4 138±14
41.4±0.2 64.5±4 205±16
41.2±0.3 58.6±5 188±16
40.8±0.2 58.2±5 184±15
40.7±0.2 66.9±4 213±13
41.6±0.2 43.1±5 138±16
41.5±0.2 43.5±4 138±13
41.5±0.2 44±7 138±22
41.7±0.2 41.4±6 134±20
41.7±0.2 44.4±6 138±19
41.6±0.2 43.1±4 138±13
41.5±0.2 43.1±6 138±19
41.6±0.3 44±7 138±22
41.6±0.2 42±8 134±25
41.6±0.3 44±6 138±19
Table 2
Thermodynamic parameters obtained by DSC after addition of haloperidol, risperidone
and 9-OH-risperidone to DPPC/cholesterol (95/5 mol/mol). AP/L ratio (mol/mol): 1/100,
1/50, 1/25 and 1/10 were studied for all AP.
AP drug AP/Lipid Ratio Tm (°C) ΔH main
transition
(KJ/mol)
ΔS main
transition
(J/mol)
HAL DPPC/Cholesterol alone 40.8±0.2 31.9±4 100±12
1/100 40.6±0.2 30.6±3 96±9
1/50 40.4±0.3 31.4±3 100±9
1/25 40.2±0.3 36.8±4 117±13
1/10 40±0.2 33.9±4 109±13
9-OH-RIS DPPC/Cholesterol alone 40.8±0.2 31.4±3 100±10
1/100 40.8±0.3 31.4±3 100±10
1/50 41±0.2 31.8±4 100±13
1/25 41.1±0.2 32.2±4 100±12
1/10 41.1±0.3 32.6±4 105±13
RIS DPPC/Cholesterol alone 40.8±0.2 31.4±3 100±10
1/100 41±0.3 32.2±3 100±9
1/50 41.1±0.2 32.6±4 105±13
1/25 41.2±0.3 33.9±5 109±16
1/10 41.4±0.1 34.7±4 109±13
Note: experiments were performed 3 times.
2014 I. Alves et al. / Biochimica et Biophysica Acta 1808 (2011) 2009–2018between the ligands and the POPC/water system were only observed
for two of the ﬁnal nine lowest energy HAL conformers (Fig. 4f), more
speciﬁcally between the 4-hydroxyl group and the phosphate head-
group of POPC. Its globular and very hydrophobic structure as well as
it positioning in the membrane could resemble that of cholesterol.
Contrarily to HAL, bent structures are rarely observed for either RIS
and 9-OH-RIS, these molecules tend to orient with its molecular
principal axis in a perpendicular manner compared with bilayer
surface (vertically), establishing contacts both at the level of the
bilayer core through the 6-ﬂuoro-benzisoxazole group and the
pyrimidin part orienting towards the solvent. When comparing with
HAL, both RIS (Fig. 4c and d) and 9-OH-RIS (Fig. 4a and b) reach
deeper into the POPC fatty acid chains, mostly due to the hydrophobic
nature and non-bent structure. 9-OH-RIS, when comparing to RIS, has
the pyrimidin part more exposed to solvent and is able to maintain H-
bonds with the solvent while RIS cannot. In a scale of exposure to the
water 9-OH-RIS is the most exposed followed by RIS and then by HAL.
In a scale of reaching deeper into the bilayer hydrophobic core RIS
reaches the deepest (Fig. 4c) followed by 9-OH-RIS (Fig. 4b) and
ﬁnally HAL (Fig. 4e). The difference between RIS and 9-OH-RIS inTable 3
Haloperidol, risperidone and 9-OH-risperidone afﬁnity and the subsequent spectral (for
p- and s-polarized light), mass and structural changes on egg PC, egg PC/brain SM (75/
25 mol/mol) and egg PC/cholesterol (95/5 mol/mol), brain SM and brain SM/
cholesterol (95/5 mol/mol), investigated by plasmon waveguide resonance.
Lipid
mixtures
AP
drugs
KD
(μM)
PWR spectral shifts
p-/s-pol
Mass changes/
structural changes (%)
Egg PC HAL 45±8 +12/+4 72/28
9-OH-RIS 17±4 +4/+21 58/42
RIS 50±13 +13/+5 82/18
Egg PC/Brain
SM
HAL 5±0.8 +5/+15 65/35
9-OH-RIS 1±0.3 +22/+11 80/20
RIS 2.2±0.5 -35/+40 32/68
Egg PC/
cholesterol
HAL 1±0.2 +8/+10 81/19
9-OH-RIS 0.12±0.02 +7/+26 70/30
RIS 0.03±0.04 -15/+20 35/65
Brain SM HAL 4±0.2 +5/+16 63/27
9-OH-RIS 0.9±0.1 +21/+10 79/21
RIS 2±0.1 -33/+38 32/68
Brain SM/
cholesterol
HAL 0.9±0.08 +8/+9 83/17
9-OH-RIS 0.1±0.02 +6/+23 61/39
RIS 0.01±0.002 -14/+18 34/66
Note: experiments were performed 3 times, no deviations were observed in the net
spectral changes, consequently no changes in the mass and structural changes
percentages.terms of deepness of penetration is quite subtle and is probably driven
by the fact that 9-OH-RIS makes H-bonds with the solvent while RIS
does not.4. Discussion
Overall, the results above described are showing a different effect
of APs on lipid mixtures. This is of particular interest for RIS and 9-
OH-RIS. These two compounds presenting a similar D2/5HT2 binding
proﬁle [18], hence supposed to exhibit similar pharmacological
activity, can be possibly differentiated in their biological activity
because they induce a different lipid reorganization in the
membrane.
In our experimental approach, the use of several biophysical
methods characterized by its speciﬁc sensitivity does not allow direct
comparison based on a common lipid/AP design. This is why some
mixtures and AP/lipid ratios were excluded for some methods, but
chosen for others. For PWR only binary mixtures were chosen as
available PWR resolution does not allow distinction between two
coexisting liquid phases as found in ternarymixtures. For ﬂuorescence
microscopy, because egg PC/cholesterol and brain SM/cholesterol did
not exhibit phase separation at microscopy scale, these mixtures were
not shown. In the ternarymixtures, cholesterol concentrationwas low
because cholesterol induces Lo/Ld phase separation in an egg PC/brain
SM/cholesterol mixture as soon as 10 mol%. Furthermore, higher
cholesterol concentration was less relevant to differentiate the effect
induced by AP addition in the mixtures. Higher and more physiolog-
ical cholesterol concentration could be used for X-ray diffraction
methods. This was the uniquemethod able to exhibit and differentiate
AP effect in this canonical mixture, while all other methods required
smaller cholesterol concentration. For docking calculations, palmi-
toyl-oleoyl-phophatidylcholine (POPC)was chosen because this is the
most used lipid model system in this type of studies, whose
coordinates for modeling are already available. Moreover, POPC,
being a major lipid component in eukaryotic membranes, constitutes
a good mimic of a ﬂuid membrane bilayer and has been extensively
used in docking calculations.
Calorimetric measurements are clearly showing on the DPPC/
cholesterol (95/5 mol/mol) mixture that both RIS and 9-OH-RIS lead
to an increase in the Tm and ΔH and a thinning of the transition peak
(increase in cooperativity of the transition). This result is explained
by a more favorable interaction of the AP with cholesterol and a
recruitment of cholesterol from the DPPC/cholesterol mixture. The
DPPC is segregated leading to a lipid phase transition that resembles
more that of the DPPC alone (in absence of cholesterol). The induction
of lipid recruitment or segregation by membrane active molecules
has been observed by DSC [45,46]. This lipid reorganization andTable 4
Micron-scale miscibility transition temperatures for egg PC/brain SM (50/50 mol/mol)
and egg PC/brain SM/cholesterol (45/45/10 mol/mol/mol) mixtures investigated by
ﬂuorescence microscopy. AP/L ratio (mol/mol): 1/10.
Lipid mixtures AP/L ratio
(1/10)
T micron-scale miscibility
transition temperature
Lβ/Ld
Egg PC/brain SM
(50/50)
Control 28.4±1.8 °C
HAL 24.3±1.4 °C
9-OH-RIS 23.6±1.3 °C
RIS 15.2±2.1 °C
Lo/Ld Lβ/Lo/Ld
Egg PC/brain SM/cholesterol
(45/45/10)
Control 23.3±1.4 °C 14.6±2.2 °C
HAL 21.4±1.2 °C 11.7±1.9 °C
9-OH-RIS 20.5±1.3 °C 7.5±2.4 °C
RIS 19.7±1.2 °C 3.7±1.6 °C
Fig. 2. Fluorescence microscopy of egg PC/brain SM/cholesterol mixture (45/45/10 mol/mol/mol) and the same mixture after AP addition (AP/L ratio: 1/10). Top line corresponds to
the control mixture (a–d), the next following lines stand for HAL (e–h), 9-OH-RIS (i–l) and RIS (m–p), respectively, from top to bottom. In the control mixture, perfectly round-
shaped domains are visible (in dark) as well as their fusion (indicated by arrows) until 15 °C (b and c). Fusion of these Lo domains was still observable at 12 °C, 8 °C and 4 °C for
mixtures comprising HAL (f and g), 9-OH-RIS (i–k), RIS (n–p). For the control mixture, below 15 °C, non-circular-shaped domains are observable, indicative of gel phase existence in
conjunction with Lo/Ld (d). Similar domains can be detected below 12 °C, 8 °C and 4 °C for HAL (h), 9-OH-RIS (l), and RIS (p), respectively. Scale bar: 20 μm.
2015I. Alves et al. / Biochimica et Biophysica Acta 1808 (2011) 2009–2018recruitment are more important for RIS than 9-OH-RIS. HAL has the
opposite effect and leads to a decrease in Tm. HAL induced a decrease
in the cooperativity of the transition – a cholesterol-type behavior –
and seems to intercalate in between the fatty acid chains, decreasing
the cooperativity of the transition by van der Waals disruption. The
recruitment of cholesterol and segregation of DPPC by RIS and 9-OH-
RIS correlate well with the fact that these molecules do not affect the
lipid phase transition of DPPC.
PWR shows that the presence of brain SM increases by about 10- to
20-fold the afﬁnity of all the AP for the bilayer. DSC studies suggest
that the APs have a small effect on brain SM lipid phase transition
(data not shown), suggesting that their interaction occurs mainly at
the headgroup level without intercalation in the fatty acid chain
region. An even larger increase in afﬁnity was observed when
cholesterol was present, especially in the case of RIS and 9-OH-RIS
addition which correlates well with the cholesterol recruitment
observed by DSC in the DPPC/cholesterol (95/5 mol/mol) mixture.Regarding the spectral changes observed upon AP drug interaction,
they are related to structural reorganization induced by those
molecules in the lipid bilayer which include both changes in mass
and structure. Spectral changes induced by the AP drug interaction
with the lipid came predominantly frommass changes, except for the
interaction of RIS with egg PC/brain SM, egg PC/cholesterol, brain SM
and brain SM/cholesterol lipid mixtures where structural changes
predominate. Changes in mass, in this case increases in mass, are
induced by the AP. Such mass increase arises both from the mass of
the molecule itself (that is in contact with the lipid bilayer so it will
contribute to its overall mass) and also from lipid reorganization (e.g.,
changes in the lipid packing) that would result in lipid inﬂux from the
plateau Gibbs border into the bilayer. Such changes in mass coming
from lipid reorganization are likely to be accompanied by changes in
structure of the lipid (considering the size of the AP drugs their
structure reorganization upon lipid contact will be small). Regarding
AP induced lipid structural reorganization, it is clear that RIS and 9-
Fig. 3. Electron density proﬁles of egg PC/brain SM/cholesterol mixture (33/33/34 mol/mol/mol). Top curve corresponds to the control condition. Underneath curves represent the
same mixture after AP addition (AP/L ratio 1/200). Left panel is showing the EDP for the liquid-disordered phase (Ld) and right panel EDP for the liquid-ordered phase (Lo).
2016 I. Alves et al. / Biochimica et Biophysica Acta 1808 (2011) 2009–2018OH-RIS led to very different effects on the membrane with RIS leading
mostly to structural changes and 9-OH-RIS leading mostly to mass
changes (more similar to HAL comportment).
Docking studies with POPC indicate that while HAL adopts a bent
structure with strong hydrophobic interactions between the rings, RIS
and 9-OH-RIS adopt an unfolded structure. The consequence is that
HAL forms a more voluminous molecule and penetrates less deep in
the membrane. The higher volume occupied by this molecule may
explain its higher perturbation in the fatty acid chain packing
observed by DSC. By looking at the docking studies one would expect
that both RIS and 9-OH-RIS would affect PC phase transition as they
are deeply inserted between the fatty acid chains. The absence of fatty
acid perturbation (DSC studies) observed for these two APs on DPPC
may come from the fact that DPPC possess saturated fatty acid chainsFig. 4. Docking results representing the lowest energy structures predicted by Autodock for
average conformation from a total of nine lowest energy structures analyzed (seen on the l
phosphate groups of the top monolayer are represented in green rods, while the fatty acidwhile POPC possess unsaturated one and so DPPC is not ﬂuid enough
to let these two APs penetrate the fatty acid region. The strikingly
favorable interaction of RIS and 9-OH-RIS with cholesterol, with both
a recruitment of cholesterol from the cholesterol/PC mixture (DSC
studies) and higher afﬁnity (PWR) could be a result of favorable
hydrophobic interactions between these two APs and cholesterol. In
the case of HAL this was not observed because the structure is bent.
The hydrophobic contacts are reduced and hydrophobic interactions
are already satisﬁed intramolecularly; therefore, this AP will not
recruit cholesterol but rather behave like cholesterol by intercalating
and greatly perturbing the fatty acid chain packing. The slightly
greater penetration of RIS compared to 9-OH-RIS may explain its
larger effect on the DPPC/cholesterol phase transition and more
pronounced effects observed by microscopy.the interaction with a pre-equilibrated bilayer of POPC. The upper panels represent an
ower panels) for the following APs: 9-OH-RIS (a, b) RIS (c, d) and HAL (e, f). The POPC
chains in black wires.
2017I. Alves et al. / Biochimica et Biophysica Acta 1808 (2011) 2009–2018Fluorescence microscopy also evidenced that antipsychotic addi-
tion led to a decrease in the temperature of gel domain formation and
their fraction, revealing that those compounds decreased the ability of
SM to segregate and form gel phase domains. These effects are
governed by the AP chemical structure. For instance, RIS addition is
associated with a stronger decrease in Tm and gel fraction compared
to 9-OH-RIS and HAL on the egg PC/brain SM mixture. This effect
cannot be explained by a higher afﬁnity of RIS compared to 9-OH-RIS.
On the contrary, 9-OH-RIS had a 2-fold higher afﬁnity compared to RIS
(PWR data). Docking data are suggesting an explanation for this
striking result. RIS higher disruptive property on gel domains may
result from its mode of intercalation in the lipid bilayer. Indeed, RIS
position across the whole monolayer reaches the deepest hydropho-
bic part where its effect is more pronounced on the acyl chains
packing compared to the less penetrating 9-OH-RIS. Fluorescence
microscopy and PWR gave complementary results in distinguishing
differences between APs with ﬂuorescence microscopy being able to
visualize micron-scale structural changes predicted by the PWR
method.
The studied egg PC/brain SM/cholesterol ternary mixture is of
interest as it mimics raft-like domains surrounded by more ﬂuid lipid
matrix. This mixture exhibited round-shaped Lo domains in the 23–
15 °C temperatures range and non-circular domains below 15 °C.
These latest are assigned to Lβ/Lo/Ld coexisting phases in the condition
where cholesterol content is low (10 mol%). AP addition induced
persistence of the ﬂuid round-shaped Lo domains at lower tempera-
tures compared to control. This effect is consistent with results
obtained for the egg PC/brain SM mixture where AP addition was
associated with a reduced Lβ formation. In the low cholesterol ternary
studied mixture, cholesterol is engaged with some SM molecules to
form Lo domains surrounded by a matrix mainly composed of PC and
remaining SM. Interestingly, PWR data are shedding some light to this
phenomenon, showing greater afﬁnity of APs for SM/cholesterol
mixture compared to PC/SM one. Of interest, all APs behave
differently regarding domain formation in this cholesterol containing
mixture. For instance, RIS induced a more pronounced effect on Lo
formation inducing liquid domains even at 4 °C compared to 9-OH-RIS
and HAL. This effect is in accordance with PWR results where
cholesterol addition to either PC or SM led to the following AP ranking
regarding afﬁnity and structural changes: RIS N9-OH-RISNHAL.
The observed changes of micron-scale miscibility transition
temperature may result from the effect of APs on the line tension.
Line tension was demonstrated to be related to the thickness
difference between the coexisting domains of the bilayer and
miscibility transition temperature [47]. A putative explanation of
the APs ability to modify the line tension may result from a previously
demonstrated result showing that APs are able to change the Lo and Ld
bilayer thickness in a mixture comprising the lipids used in the
current study [9].
Antipsychotic addition to the egg PC/brain SM/cholesterol (33/33/
34) mixture modiﬁed the EDP for both Lo and Ld phases. As it was
mentioned above, our previous study indicates that all three AP
induced a Lo phase bilayer thickness decrease, with only RIS leading to
Ld bilayer thickness decrease [9]. The AP effect on EDP is more
pronounced for RIS and 9-OH-RIS than for HAL. The existence of
shoulder in Lo phase for the control condition, a consistent ﬁnding in
cholesterol-containing liposomes, can be explained by two factors: 1.
cholesterol increases the order in the hydro carbon region, thereby
localizing the terminal methyl group in the center of the bilayer; 2. the
electron density of cholesterol steroid rings is greater than the
electron density of the phospholipid methylene chains [31,48,49]. The
observed changes in EDP after AP addition in this region are likely to
result from interference between AP and cholesterol. This point is in
accordance with DSC results showing that AP addition to DPPC/
cholesterol mixture leads to a thermogram approaching that of pure
DPPC, indicative of a segregating effect of these compounds oncholesterol (except for HAL). Electron density proﬁle modiﬁcation
obtained after addition of 9-OH-RIS suggests existence of two
phenomena: 1. a relative cholesterol deprivation of the Lo phase,
evidenced by the shoulder attenuation of the EDP; 2. a relative
cholesterol enrichment of the Ld phase that may explain the shoulder
appearance in the EDP. This effect may not result from 9-OH-RIS
intercalation as previous results described with PC/SM mixture are
favoring a better partition of 9-OH-RIS in SM domains. Addition of RIS
in the mixture led, on the Lo phase, to a similar effect of shoulder
disappearance as seen with 9-OH-RIS, but more pronounced.
Meanwhile, no shoulder was seen on the Ld phase EDP. These effects
may be similarly interpreted for 9-OH-RIS by the expelling effect of
this AP on cholesterol in the Lo phase. Observed differences between
RIS and 9-OH-RIS on EDP may result from structural changes induced
by RIS, changes that surpass cholesterol movements between the two
phases. Methylene chains and fatty acid chains disorganization by RIS
led to a total disappearance of the shoulder in the Lo EDP as well as the
absence of such shoulder in Ld EDP. This latter is likely to be caused by
the inability of cholesterol nuclei to get organized in an accurate
alignment at a precise depth in the bilayer [50].
5. Conclusions
Overall, the studies performed here indicate that AP compounds
interact with lipids and induce membrane reorganization. These
effects differ depending on the lipid and AP nature, with major
interaction for sphingolipids, in particular when included in hetero-
geneous mixtures. Cholesterol is also a potent modifying factor
regarding AP afﬁnity to the bilayer. Moreover, a synergistic effect is
observed in SM/cholesterol mixtures. The AP chemical structure is
inﬂuencing the extent to which these effects occur. A good example of
that is observedwhen comparing 9-OH-RIS and RIS, with RIS inducing
stronger membrane structural changes.
Among studied lipid mixtures, those containing SM and choles-
terol are mimicking lateral heterogeneity in cell membranes which
stands for raft-like domains, membrane loci where many biological
signaling events occur. The fact that APsmodify raft-like domainsmay
have some consequences in clinical practice as these compounds are
used in medicine at high dosages and for long periods of time. Present
results indicate that AP drugs may have a consequence in membrane
compartmentalization. It is well known that AP pharmacological
activity results from their binding to the dopamine D2 receptor, the
present study suggests that AP can also modify the receptor behavior
through changes of the lipid receptor environment. This assumption is
currently under examination in vitro with measure of receptor
activity after introduction of AP on the lipid bilayer.
Supplementarymaterials related to this article can be found online
at doi: 10.1016/j.bbamem.2011.02.021.
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